Hematoxylin, an Alternative Substrate of Tyrosinase

Chantalle Crous,Ivanke A. Swart,Judey Pretorius,Frank van der Kooy,Jacobus P. Petzer,Anél Petzer
DOI: https://doi.org/10.1055/a-2381-5201
IF: 3.007
2024-08-21
Planta Medica
Abstract:Mushroom tyrosinase from Agaricus bisporus ( ab TYR) is often used during the development of tyrosinase inhibitors for medicinal and cosmetic purposes. In the search for novel tyrosinase inhibitors, this study identified hematoxylin as an alternative substrate for ab TYR. The interaction of hematoxylin with ab TYR was investigated through spectrophotometric and chromatographic analyses. The results showed that hematoxylin acted as an ab TYR substrate and exhibited Michaelis–Menten kinetic behaviour at concentrations below 1.25 mM. The substrate properties of hematoxylin were similar to the natural tyrosinase substrate, L-3,4-dihydroxyphenylalanine (L-DOPA), with regards to K m , while V max was eightfold lower. The main oxidation product formed during the reaction of ab TYR with hematoxylin was identified as hematein. This is the first report of the interaction of hematoxylin with ab TYR. Received: 28 May 2024 Accepted after revision: 30 July 2024 Article published online: 19 August 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
What problem does this paper attempt to address?